BioSpace News Archive

Parexel, a leading global clinical research organization focused on development and delivery of innovative new therapies to advance patient health, announced the appointment of five former regulators to its Regulatory & Access Consulting team, further accelerating the advancement of new treatments for patients worldwide.

Medigus Ltd. announced that the Company filed a motion with the Tel Aviv District Court Economic Department for approval of a dividend distribution up to of $1.6 million.

Sciton Inc., a leading manufacturer of medical and aesthetic lasers and light sources, proudly announces the 510K FDA tool clearance received on July 16 for their diVa handpiece.

Purissima, a leading biotechnology health and wellness company, announced the completion of two separate ingredient testing programs with two leading contract research organizations.

BrainChip Holdings Ltd, the world’s first commercial producer of ultra-low power neuromorphic AI IP, is exhibiting at both Edge AI Summit and AI Hardware Summit, which are being held concurrently at the Santa Clara Marriott in Santa Clara, Calif., September 13-15.

Surgeons, oncologists, and researchers all agree: When it comes to understanding complex and deadly brain tumors, tissue is the issue.

The global bioburden testing market is projected to grow at a CAGR of 12.7%, in terms of value, from 2016 to reach USD 1,611.8 Million by 2028.

The global AI-based clinical trials solution provider market size reached USD 1.24 Billion in 2020 and is expected to register a revenue CAGR of 21.5% during the forecast period, according to latest analysis by Emergen Research

The Merck Foundation (the Foundation) announced today the launch of the Alliance for Equity in Cancer Care (the Alliance), a $20 million, five-year initiative, designed to make cancer care more equitable in the United States by helping patients living in underserved communities receive timely access to high-quality, culturally responsive care.

Applied DNA Sciences, Inc., a leader in polymerase chain reaction -based technologies, and the Cornell University College of Veterinary Medicine announced the signing of a research agreement to advance LinearDNA™-based vaccine research and discovery for animal diseases with agricultural biosecurity implications.